PRIMA-1MET decreased tumor volume and growth in mice bearing mut-p53 glioma cells in the flank, correlating with low levels of xCT; the authors suggested that PRIMA-1MET exerts its cytotoxic effect by damaging the antioxidant system of GSCs [340]. The gene discussed is TP53; the disease is central nervous system cancer.